| Maxwell Hogue, | |
|
375 Wampanoag Trl, Riverside, RI 02915-2232 | |
| (401) 649-4020 | |
| (401) 649-4021 |
| Full Name | Maxwell Hogue |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 375 Wampanoag Trl, Riverside, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235789231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN2313022 (Massachusetts) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | APRN02399 (Rhode Island) | Primary |
| Entity Name | Brown Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689626764 PECOS PAC ID: 0446159776 Enrollment ID: O20040219000354 |
News Archive
Obesity, insulin resistance and Type 2 diabetes are risk factors for breast cancer in post-menopausal women. The metabolic and inflammatory complications of obesity have a role in the formation of cancer.
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company out of India, today announced the repayment of FCCBs amounting to US$ 50 million along with the YTM of US$ 19 million. The FCCBs were due for redemption on May 24, 2010.
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.
New recommendations published by the American Society of Nuclear Cardiology (www.asnc.org) could significantly lower radiation exposure for patients undergoing myocardial perfusion imaging (MPI) procedures. Focused on three areas — patient selection, test selection, and technology adoption — ASNC's information statement summarizes best practices for minimizing radiation exposure without sacrificing quality or clinical benefit to the patient.
› Verified 7 days ago
| Entity Name | Wickford Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710698667 PECOS PAC ID: 6305218876 Enrollment ID: O20230209000992 |
News Archive
Obesity, insulin resistance and Type 2 diabetes are risk factors for breast cancer in post-menopausal women. The metabolic and inflammatory complications of obesity have a role in the formation of cancer.
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company out of India, today announced the repayment of FCCBs amounting to US$ 50 million along with the YTM of US$ 19 million. The FCCBs were due for redemption on May 24, 2010.
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.
New recommendations published by the American Society of Nuclear Cardiology (www.asnc.org) could significantly lower radiation exposure for patients undergoing myocardial perfusion imaging (MPI) procedures. Focused on three areas — patient selection, test selection, and technology adoption — ASNC's information statement summarizes best practices for minimizing radiation exposure without sacrificing quality or clinical benefit to the patient.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maxwell Hogue, 619 Boston Neck Rd, North Kingstown, RI 02852-6235 Ph: (603) 667-6765 | Maxwell Hogue, 375 Wampanoag Trl, Riverside, RI 02915-2232 Ph: (401) 649-4020 |
News Archive
Obesity, insulin resistance and Type 2 diabetes are risk factors for breast cancer in post-menopausal women. The metabolic and inflammatory complications of obesity have a role in the formation of cancer.
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company out of India, today announced the repayment of FCCBs amounting to US$ 50 million along with the YTM of US$ 19 million. The FCCBs were due for redemption on May 24, 2010.
Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.
New recommendations published by the American Society of Nuclear Cardiology (www.asnc.org) could significantly lower radiation exposure for patients undergoing myocardial perfusion imaging (MPI) procedures. Focused on three areas — patient selection, test selection, and technology adoption — ASNC's information statement summarizes best practices for minimizing radiation exposure without sacrificing quality or clinical benefit to the patient.
› Verified 7 days ago
Penny Marie Mclean-nowinski, MSN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1445 Wampanoag Trl Unit 205, Riverside, RI 02915 Phone: 401-434-0730 Fax: 401-270-3439 | |
Mrs. Shannon Fultz, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3 Myrtle Ave, Riverside, RI 02915 Phone: 603-765-1431 | |
Donna Marie Rondeau-marzullo, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 102, Riverside, RI 02915 Phone: 401-649-4010 Fax: 401-649-4011 | |
Ms. Kelley Anne Nelligan, RN, MSN, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1011 Veterans Memorial Pkwy, Riverside, RI 02915 Phone: 401-432-1325 | |
Miss Paula Holmes Constantine, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 375 Wampanoag Trl Ste 102, Riverside, RI 02915 Phone: 401-649-4010 Fax: 401-649-4011 | |
Ms. Britni Turano, MS RN PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1445 Wampanoag Trl Unit 202, Riverside, RI 02915 Phone: 401-437-4116 | |
Mr. David John Ramos, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 501 Wampanoag Trl Unit 102, Riverside, RI 02915 Phone: 401-435-3325 Fax: 401-435-3327 |